-
Mashup Score: 8Regeneron Pharmaceuticals: Delivering Life-transforming Medicines - 5 month(s) ago
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
Source: www.regeneron.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0The Regeneron Journey: 2020 Edition - 4 year(s) ago
Following an Emergency Use Authorization for the REGN-COV2 investigational antibody cocktail, Len Schleifer, MD, PhD, Founder and CEO, reflects on what the Regeneron team has accomplished so far in 2020.
Source: www.regeneron.comCategories: Future of Medicine, Latest HeadlinesTweet-
The Regeneron Journey: 2020 Edition. Right from the CEO. @Regeneron #COVID19 #coronavirus #vaccine https://t.co/LlknARQmWa
-
-
Mashup Score: 8The Regeneron Journey: 2020 Edition - 4 year(s) ago
Following an Emergency Use Authorization for the REGN-COV2 investigational antibody cocktail, Len Schleifer, MD, PhD, Founder and CEO, reflects on what the Regeneron team has accomplished so far in 2020.
Source: www.regeneron.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Regeneron CEO Len Schleifer pens blog post re: the company's COVID EUA. https://t.co/ZsLBeSKP9n
-
Visit us at #ASH23 (booth 633) to discover how our team is striving to make a big impact through our efforts in hematology – because we know that for patients living with these difficult-to-treat blood cancers and disorders, every moment matters. https://t.co/sdEq604j3p https://t.co/csG6cbBijg